Skip to main content
    A

    Actinium Pharmaceuticals Inc (ATNM)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • AMEX

    $1.49
    -0.15 (-9.45%)

    Market Cap: $51.56M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    Actinium Pharmaceuticals Inc (ATNM) Earnings: Report Dates and Results

    Updated Aug 7, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Actinium Pharmaceuticals (ATNM) is expected to report earnings on Mar 29, 2027. In the quarter ended Jun 30, 2026, Actinium Pharmaceuticals reported EPS of $0.89, above the -$0.20 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    59%(23/39)
    Avg Surprise
    +21.52%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 29, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.24
    Range-$0.31 - -$0.15
    5 analysts
    Revenue Consensus
    N/A
    RangeN/A
    5 analysts

    Next Report

    ATNM has an expected report date of Mar 29, 2027.

    Earnings History

    Of the 40 quarters below that had an estimate, ATNM beat 24, missed 11 and matched 5. The widest gap in the table came in the quarter ended Jun 30, 2026, when EPS landed 545.00% above the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026$0.89-$0.20-$0.20 - -$0.20+545.00%BeatN/A12 up, 0 downAug 7, 2026$35.00M
    Mar 31, 2026-$0.18-$0.22-$0.22 - -$0.22+18.18%BeatN/A30 up, 1 downMay 8, 2026N/A
    Dec 31, 2025-$0.19-$0.18-$0.20 - -$0.17-5.78%MissN/A32 up, 1 downMar 30, 2026N/A
    Sep 30, 2025-$0.16-$0.32-$0.48 - -$0.24+50.00%BeatN/A31 up, 0 downNov 14, 2025$90000
    Jun 30, 2025-$0.22-$0.35-$0.46 - -$0.30+37.14%BeatN/A40 up, 2 downAug 8, 2025N/A
    Mar 31, 2025-$0.51-$0.28-$0.35 - -$0.24-82.14%MissN/A40 up, 0 downMay 9, 2025N/A
    Dec 31, 2024-$0.21-$0.39-$0.44 - -$0.29+46.15%BeatN/A40 up, 3 downMar 31, 2025$810000
    Sep 30, 2024-$0.37-$0.37-$0.40 - -$0.250.00%In lineN/A50 up, 0 downNov 14, 2024N/A
    Jun 30, 2024-$0.38-$0.40-$0.58 - -$0.31+5.00%BeatN/A60 up, 0 downAug 5, 2024N/A
    Mar 31, 2024-$0.31-$0.52-$0.65 - -$0.42+40.38%BeatN/A31 up, 0 downApr 26, 2024N/A
    Dec 31, 2023-$0.33-$0.54-$0.61 - -$0.48+38.89%BeatN/A50 up, 0 downMar 29, 2024$81000
    Sep 30, 2023-$0.49-$0.57-$0.73 - -$0.38+14.04%BeatN/A61 up, 0 downNov 2, 2023N/A
    Jun 30, 2023-$0.58-$0.49-$0.58 - -$0.44-18.37%MissN/A50 up, 0 downAug 14, 2023N/A
    Mar 31, 2023-$0.43-$0.43-$0.47 - -$0.370.00%In lineN/A60 up, 0 downApr 3, 2023N/A
    Dec 31, 2022-$0.43-$0.35-$0.43 - -$0.09-22.86%MissN/A60 up, 0 downMar 31, 2023N/A
    Sep 30, 2022-$0.38-$0.31-$0.35 - -$0.22-22.58%MissN/A61 up, 0 downNov 14, 2022$45000
    Jun 30, 2022-$0.33-$0.23-$0.28 - $1.29-43.48%MissN/A20 up, 0 downAug 12, 2022$90000
    Mar 31, 2022-$0.23-$0.31-$0.36 - -$0.26+25.81%BeatN/A40 up, 0 downMay 13, 2022$1.88M
    Dec 31, 2021-$0.36-$0.30-$0.34 - -$0.26-20.00%MissN/A40 up, 0 downMar 25, 2022$1.17M
    Sep 30, 2021-$0.30-$0.28-$0.28 - -$0.28-7.14%MissN/A20 up, 0 downNov 12, 2021$233000
    Jun 30, 2021-$0.25-$0.29-$0.34 - -$0.25+13.79%BeatN/A4N/AJul 30, 2021$266000
    Mar 31, 2021-$0.29-$0.34-$0.35 - -$0.19+14.71%BeatN/A3N/AMay 14, 2021$622000
    Dec 31, 2020-$0.37-$0.37-$0.44 - -$0.240.00%In lineN/A5N/AMar 31, 2021N/A
    Sep 30, 2020-$0.36-$0.46-$0.59 - -$0.33+21.74%BeatN/A4N/AOct 23, 2020N/A
    Jun 30, 2020-$0.41-$0.40-$0.60 - -$0.30-2.50%MissN/A3N/AAug 14, 2020N/A
    Mar 31, 2020-$0.90-$1.20-$1.20 - -$0.30+25.00%BeatN/A3N/AMay 8, 2020N/A
    Dec 31, 2019-$0.90-$1.20-$1.20 - -$1.20+25.00%BeatN/A3N/AMar 13, 2020N/A
    Sep 30, 2019-$1.20-$1.20-$1.20 - -$0.900.00%In lineN/A3N/ANov 12, 2019N/A
    Jun 30, 2019-$0.90-$1.50-$1.50 - -$0.90+40.00%BeatN/A3N/AAug 9, 2019N/A
    Mar 31, 2019-$1.50-$1.70-$1.80 - -$1.50+11.76%BeatN/A3N/AMay 10, 2019N/A
    Dec 31, 2018-$1.50-$1.80N/A+16.67%BeatN/AN/AN/AMar 19, 2019N/A
    Sep 30, 2018-$1.80-$1.35N/A-33.33%MissN/AN/AN/ANov 9, 2018N/A
    Jun 30, 2018-$1.20-$1.90-$2.10 - -$1.80+36.84%BeatN/A4N/AAug 9, 2018N/A
    Mar 31, 2018-$2.10-$2.70N/A+22.22%BeatN/A3N/AMay 10, 2018N/A
    Dec 31, 2017-$1.80-$2.62-$3.00 - -$2.40+31.30%BeatN/A4N/AMar 16, 2018N/A
    Sep 30, 2017-$2.70-$2.70N/A0.00%In lineN/AN/AN/ANov 3, 2017N/A
    Jun 30, 2017-$3.60-$4.05N/A+11.11%BeatN/AN/AN/AAug 4, 2017N/A
    Mar 31, 2017-$4.20-$3.90N/A-7.69%MissN/AN/AN/AMay 15, 2017N/A
    Dec 31, 2016-$3.60-$4.20N/A+14.29%BeatN/AN/AN/AMar 16, 2017N/A
    Sep 30, 2016-$4.20-$4.95N/A+15.15%BeatN/AN/AN/AOct 28, 2016N/A
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.08, after -$1.27 the year before. It was -$15.30 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.08N/A
    Dec 31, 2024-$1.27N/A
    Dec 31, 2023-$1.83N/A
    Dec 31, 2022-$1.37N/A
    Dec 31, 2021-$1.20N/A
    Dec 31, 2020-$2.04N/A
    Dec 31, 2019-$4.50N/A
    Dec 31, 2018-$6.60N/A
    Dec 31, 2017-$12.30N/A
    Dec 31, 2016-$15.30N/A

    Frequently Asked Questions About ATNM

    When is Actinium Pharmaceuticals's next earnings date?

    Actinium Pharmaceuticals's next earnings report is expected for Mar 29, 2027.

    Did ATNM beat earnings estimates last quarter?

    Yes. Actinium Pharmaceuticals reported EPS of $0.89 for the quarter ended Jun 30, 2026, above the -$0.20 estimate, a 545.00% surprise.

    What EPS do analysts expect from ATNM next quarter?

    The consensus EPS estimate for Actinium Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.24 from 5 analysts, with estimates from -$0.31 to -$0.15.

    How often does ATNM beat earnings estimates?

    Actinium Pharmaceuticals beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +76.07%.